Growth hormone therapy and malignancy

Hormone Research in Paediatrics

Volumn 48, Issue 4, 1997, Pages 29-32

  Shalet, S M ^a   Brennan, B M ^a   Reddingius, R E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Brain tumour; Growth hormone; Leukaemia; Safety

Indexed keywords

HUMAN GROWTH HORMONE;

ACROMEGALY; BRAIN TUMOR; CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CONFERENCE PAPER; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; RISK; STATISTICAL ANALYSIS;

ACROMEGALY; CHILD; CLUSTER ANALYSIS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; JAPAN; LEUKEMIA; NEOPLASMS; RADIATION INJURIES; RECURRENCE;

EID: 0030723307     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000191309     Document Type: Article

References (13)

1. Moon HD. Simpson ME, Li CH. Evans HM: Neoplasms in rats with pituitary growth hormone I. Pulmonary and lymphatic tissues. Cancer Res 1950;10:297-308.
2. Moon HD. Li CH. Simpson ME: Effect of pituitary hormones on carcinogenesis with 9, 10-dimethyl- 1,2-dibenzanthracenc in hypophysectomized rats. Cancer Res 1956:16:111-116.
3. Bentley HB. Hughes ER. Peterson RDA: Effect of hypophysectomy on a virus-induced T-cell leukaemia. Nature 1974;252:747-748.
4. Blatt J. Wenger S. Stitely S. Lee PA: Lack of mitogenic effects of growth hormone on human leukemic lymphoblasts. Eur J Pediatr 1987; 146:257-260.
5. Estrov Z. Meir R. Barak Y, Zaizov R. Zadik Z: Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukaemic cells. J Clin Oncol 1991:9: 394-399.
6. Mercola K.E. Cline MJ. Golde DW: Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood 1981:58:337-340.
7. Watanabc S. Mizuno S. Tsunemalsu Y, Kom-iyama A, Yamanaka C, Kubota M: Leukemia in GH deficient children. Clin Pediatr Endocrinol 1994;3(suppl 5):53-60.
8. Blethen SL, Allen DB. Graves D, August G. Moshang T, Rosenfeld R: Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience. J Clin Endocrinol Metab 1996;81:1704-1710.
9. Redmond GP. Rapaport R. Salisbury S, David R. Rao J, Obcrfield S: Leukaemia in growth hormone deficient (GHD) children who did not receive growth hormone. Pediat Res 1992: 31:83A.
10. Wilton P: Safety of growth hormonc-valuc of a large data base. Clin Pediatr Endocrinol 1994; 3(suppl 5):61-71.
11. Leiper A: Growth hormone deficiency in children treated for leukaemia. Acta Paediatr 1995;84(suppl 411):41-44.
12. Ogilvy-Stuarl AL. Ryder WDJ. Gattamaneni HR. Clayton PE. Shalct SM: Growth hormone and tumour recurrence. BMJ 1992;304:1601-1605.
13. Moshang T. Rundle AC, Graves DA. Nickas J. Johanson A, Meadows A: Brain tumour recurrence in children treated with growth hormone: The National Cooperative Growth Study experience. J Pediatr 1996; 128:S4-S7.